A pharmaceutical composition for treating hyperlipidemia with phlegm turbidity suppression syndrome

A technology of phlegm turbidity suppression syndrome and composition, which is applied in the field of pharmaceutical composition for the treatment of hyperlipidemia of phlegm turbidity suppression syndrome, can solve problems such as non-curative effects, and achieve the effects of convenient taking, quick treatment and high efficiency

Inactive Publication Date: 2017-09-15
张毅
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

It can be said that the indicator effect is great, but it does not cure the root cause

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A pharmaceutical composition for treating hyperlipidemia with phlegm turbidity suppression syndrome
  • A pharmaceutical composition for treating hyperlipidemia with phlegm turbidity suppression syndrome

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0035] The preparation of embodiment 1 capsule

[0036] Prescription: Alisma 26g, Liu Jinu 8g, Citrus aurantium 13g, Inula 15g, Shichangpu 16g, Astragalus 15g, Campanulaceae 7g, Almond 9g, Licorice 5g.

[0037] Preparation method: Take Liu Jinu, Xuanfuhua, and almonds according to the prescription amount, and use 65-75% ethanol to reflux extract 2-3 times, each time for 1-2 hours, combine the extracts, recover ethanol, concentrate the extracts, vacuum Dry to obtain the extract, crush the extract into fine powder, and pass through a 100-mesh sieve; according to the prescription amount, take Alisma alisma, Fructus Citrus Aurantii, Shichangpu, Astragalus, Platycodon grandiflorum, and licorice, grind them, mix them, and decoct them twice with water. After 1-2 hours, combine the decoction liquid, concentrate to a relative density of 1.0-1.06 (60°C), and vacuum-dry to obtain the extract, which is crushed into a fine powder and passed through a 100-mesh sieve; the fine powder obtaine...

Embodiment 2

[0038] The preparation of embodiment 2 capsules

[0039] Prescription: Alisma 21g, Liu Jinu 6g, Citrus aurantium 9g, Inula 11g, Shichangpu 10g, Astragalus 13g, Campanulaceae 6g, Almond 7g, Licorice 4g.

[0040] Preparation method: carry out with reference to Example 1.

Embodiment 3

[0041] The preparation of embodiment 3 capsules

[0042]Prescription: Alisma 24g, Liu Jinu 7g, Citrus aurantium 10g, Inula 13g, Shichangpu 13g, Astragalus 14g, Campanulaceae 7g, almond 8g, licorice 5g.

[0043] Preparation method: carry out with reference to Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the field of traditional Chinese medicine, and relates to a pharmaceutical composition for treating hyperlipidemia with phlegm turbidity obstruction syndrome, which consists of nine herbs including Alisma, Liu Jinu, Citrus aurantii, Inulae inula, Shichangpu, Astragalus, Campanulaceae, almond, and licorice Made from raw materials, the pharmaceutical composition of the present invention can lower blood fat and eliminate phlegm, promote blood circulation and purify turbidity through clinical verification, and has achieved good effect on the treatment of hyperlipidemia with phlegm turbidity suppression syndrome.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicine, in particular to a pharmaceutical composition for treating hyperlipidemia with phlegm turbidity arrest syndrome. Background technique [0002] Hyperlipidemia, also known as dyslipidemia, refers to plasma total cholesterol (TC), triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), apolipoprotein B (ApoB) One or more of them are higher than the normal level, accompanied by the reduction of high-density lipoprotein cholesterol (HDL-C) and apolipoprotein AI (ApoAI), which are common and frequently-occurring diseases in middle-aged and elderly people. With the improvement of living habits and the change of living habits, the incidence of the disease has increased significantly, and the age of onset has also advanced. In addition, hyperlipidemia is an independent risk factor for cardiovascular and cerebrovascular diseases such as coronary heart disease and cerebral apoplexy, and ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/888A61P3/06
Inventor 张毅王新霞
Owner 张毅
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap